Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

CasCure Therapeutics

Main focus: Next-generation cell therapies for autoimmune diseases

Company stage: Pre-clinical

Diseases (gene editing): Solid tumours

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Ulsan and Seoul, Korea

Website: http://cascure.com/

CasCure Therapeutics develops a novel method to selectively target and kill cancer cells using CRISPR-Cas9 technology.

Tags

HashtagCasCure Therapeutics

Company: CasCure Therapeutics
close
Search CRISPR Medicine